Publication Name	World Journal of Gastroenterology
Manuscript ID	7767
Country	Italy

Received	2013-11-30 13:36
Peer-Review Started	2013-12-02 10:42
To Make the First Decision	2013-12-16 18:07
Return for Revision	2013-12-17 16:38
Revised	2014-01-14 02:15
Second Decision	2014-03-13 16:19
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-03-13 16:30
Articles in Press	2014-05-23 09:49
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-07-07 13:28
Publish the Manuscript Online	2014-07-21 17:17

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Topic Highlights
Article Title	De-escalating therapy in gastric aggressive lymphoma
Manuscript Source	Invited Manuscript
All Author List	Rosanna Cuccurullo, Silvia Govi and Andrés JM Ferreri
Funding Agency and Grant Number
Corresponding Author	Andrés JM Ferreri, MD, Unit of Lymphoid Malignancies, Division of OncoHematological Medicine, Department of OncoHematology, San Raffaele Scientific Institute, Via Olgettina 60, 20132 Milan, Italy. ferreri.andres@hsr.it
Key Words	Diffuse large B-cell lymphoma; Gastric lymphoma; Helicobacter pylori; Antibiotic therapy; Rituximab
Core Tip	Therapeutic intensity has been progressively reduced in patients with limited-stage diffuse large B-cell lymphoma of the stomach, with a consequent improvement in tolerability and quality of life, and with unimpaired survival figures. In particular, patients with Helicobacter pylori (H. pylori)-positive lymphoma and favourable prognostic factors can be managed with antibiotics alone, with excellent disease control and cure rates, keeping chemo-radiotherapy for unresponsive patients. Future studies should be focused on the establishment of reliable variables able to distinguish the best candidates for exclusive treatment with H. pylori eradication from those who need for conventional therapy.
Publish Date	2014-07-21 17:17
Citation	Cuccurullo R, Govi S, Ferreri AJM. De-escalating therapy in gastric aggressive lymphoma. World J Gastroenterol 2014; 20(27): 8993-8997
URL	http://www.wjgnet.com/1007-9327/full/v20/i27/8993.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i27.8993

Full Article (PDF)	WJG-20-8993.pdf
Full Article (Word)	WJG-20-8993.doc
Manuscript File	7767-Review.doc
Answering Reviewers	7767-Answering reviewers.pdf
Copyright License Agreement	7767-Copyright assignment.pdf
Peer-review Report	7767-Peer review(s).pdf
Scientific Editor Work List	7767-Scientific editor work list.doc